Tamsulosin And Naftopidil Equivalent Against BPH
NEW YORK (Reuters Health) - Tamsulosin and naftopidil, two alpha1-blockers with different affinities to the alpha1 adrenoceptor (AR) subtypes, are equally safe and effective for treating the symptoms of benign prostatic hyperplasia (BPH), according to a study conducted in Japan.

Login to read more...

UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 UroToday International Journal Correspondence About The Editors | About Us | Contact Us | Report an Inaccuracy | Sponsorship Opportunities | Terms of Use Privacy Policy | © 2010 UroToday ® All Rights Reserved